.webp)
Share
Marshall Mohr
.webp "Capstan Medical Appoints Marshall Mohr to Board of Directors")
Capstan Medical, a developer of robotic-enabled minimally invasive therapies for heart valve disease, has appointed Marshall Mohr to its Board of Directors.
His addition supports the company’s efforts to advance its structural heart platform and expand patient access to next-generation treatment options.
Mohr joined Intuitive Surgical in 2006 as Senior Vice President and Chief Financial Officer, guiding the company through a transformative period of rapid growth that strengthened its leadership in robotic-assisted minimally invasive surgery. He later served as Executive Vice President of Global Business Services, overseeing the expansion of global infrastructure, operations, and commercial capabilities. Mohr currently also serves on the boards of Veeva Systems, Pacific Biosciences of California, and SRI International.
The appointment follows significant milestones for Capstan, including an oversubscribed US$110 million Series C financing in late 2024 and the successful completion of first-in-human robotic-assisted transcatheter mitral valve replacement procedures in early 2025. The procedures marked the first clinical use of a minimally invasive robotic structural heart platform to deliver a novel mitral valve implant.
With millions affected by heart valve disease in the United States, Capstan aims to address limitations of open-heart surgery and existing catheter-based therapies through its integrated robotic platform and advanced valve technologies.
Related posts
.jpg "Integra LifeSciences Appoints Dr. Raymond Turner as Chief Medical Officer")
